Abstract:The aim of the present study was to investigate the effect and mechanism of protein phosphatase 2A (PP2A) on the migration of astrocytes. The primary astrocytes of neonatal mice were isolated and cultured in vitro, and treated with the PP2A activator D‑erythro‑sphingosine (DES) (activated group) or inhibitor okadaic acid (inhibitory group). The control group was treated with equal amounts of dimethyl sulfoxide. The activity of PP2A in the cells was detected using a commercial kit and the migration of cells was investigated using a Transwell migration assay. The protein expression of p38, phosphorylated (p)‑p38, matrix metalloproteinase (MMP)‑2 and MMP‑9 was detected by western blotting. Cell migration and the protein expression of p38, p‑p38, MMP‑2 and MMP‑9 was also determined following treatment of astrocytes with the p38 signaling pathway inhibitor SB202190 with or without the PP2A activator DES. The results demonstrated that the activity of PP2A in the PP2A inhibitory group was significantly decreased compared with the control group, while that of the PP2A‑activated cells was significantly increased compared with the control. The protein levels of MMP‑2 and MMP‑9 in the PP2A inhibitory group astrocytes were significantly decreased compared with the control group, while PP2A‑activated astrocytes exhibited significantly increased levels of these proteins. By contrast, the p‑p38 level in PP2A inhibitory group astrocytes was significantly increased compared with the control group, while astrocytes in the activated group exhibited significantly lower levels compared with the control group. Furthermore, the cell migration ability, and MMP‑2 and MMP‑9 protein levels, of astrocytes that received combined treatment with SB202190 and the PP2A activator DES were significantly increased compared with the levels in astrocytes treated with SB202190 alone. The results of the current study indicate that PP2A may negatively regulate the p38 signaling pathway to promote astrocyte migration.

Protein phosphatase 2A regulates the p38 signaling pathway to affect the migration of astrocytes

Upregulation of Astrocytes Protein Phosphatase‐2a Stimulates Astrocytes Migration Via Inhibiting P38 MAPK in Tg2576 Mice

Specific Disruption of Astrocytic Ca2+ Signaling Pathway in Vivo by Adeno-Associated Viral Transduction.

Particulate Matter Facilitates C6 Glioma Cells Activation and the Release of Inflammatory Factors Through MAPK and JAK2/STAT3 Pathways

Overexpression of DSPP Promotes the Proliferation and Migration of Astrocytes

PP2A Protects Podocytes Against Adriamycin-induced Injury and Epithelial-to-mesenchymal Transition Via Suppressing JIP4/p38-MAPK Pathway

Protein Phosphatase 2A Inhibits the Invasion of Cervical Cancer Cells Through MAPK Signaling Pathway

Protein Phosphatase 2A (PP2A) Activation Promotes Axonal Growth and Recovery in the CNS.

Lysophosphatidic acid (LPA) induces the proliferation of astrocytes in rat via pathway of protein kinase C -α and calcium ion in vitro

Protein Phosphatase 2a Plays an Important Role in Migration of Bone Marrow Stroma Cells

ASPP2 Upregulation as a Novel Approach to TGF-β2-Induced Proliferative Vitreoretinopathy In Vivo and In Vitro

THE STUDY OF LYSOPHOSPHATIDIC ACID PROMOTE THE PROLIFERATION OF ASTROCYTE OF RAT THROUGH G-PROTEIN COUPLED RECEPTOR

PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK Signaling Pathway

Serum Amyloid A Inhibits Astrocyte Migration Via Activating P38 MAPK

PPARα Inhibits Astrocyte Inflammation Activation by Restoring Autophagic Flux after Transient Brain Ischemia

Stimulation of Group II Phospholipase A 2 Mrna Expression and Release in an Immortalized Astrocyte Cell Line (DITNC) by LPS, TNFα, and IL-1β

[ERK1/2 and P38 Kinases Are Important Regulators in P2Y Receptor-Mediated Prostate Cancer Invasion].

PROSTAGLANDIN E2 INDUCES THE PHOSPHORYLATION OF CREB AND GABABR2 IN CULTURED RAT ASTROCYTES

2-Arachidonyl Glycerol Modulates Astrocytic Glutamine Synthetase Via P38 and ERK1/2 Pathways

Lipopolysaccharides Affect the Production of Glutathione and TNF-α of Astrocytes Through MAPK Pathway

ERK1/2 and P38 Pathways Are Required for P2Y Receptor-Mediated Prostate Cancer Invasion.